Biocryst Pharma Inc - BCRX - stock price prediction, stock price target, analyst ratings from 11 analysts

Biocryst Pharma Inc has a share price target of US$ 21, revenue growth forecast of -19.7%, and profit growth estimate of -319.3% for FY26, based on top 11 analyst calls.